Behavioral
New Horizons Medical, INC.
New Horizons Medical, INC. was paid $11.70M by Medicaid between Jan 2018 and Dec 2024, across 19 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 33% of everything it billed.
33Billing provider infoNEW HORIZONS MEDICAL, INC.
FRAMINGHAM, MA 01702
FRAMINGHAM, MA 01702
33aNPI1487983342assigned 12/23/2009
33bProvider typeMental Health Counselor
28Total paid$11.70M
24GClaims277,925
24DCodes billed19
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Counselor providers in Massachusetts
Rank by total paid#10 of 597
Median peer was paid$53K
This provider vs. median219×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,379 | $2.22M | |
| 2019 | 48,697 | $1.79M | |
| 2020 | 40,791 | $1.78M | |
| 2021 | 34,492 | $1.61M | |
| 2022 | 28,111 | $1.28M | |
| 2023 | 36,936 | $1.66M | |
| 2024incomplete | 27,519 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 33% | 101,744 | 47,255 | $3.80M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 62,869 | 36,105 | $2.90M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 19% | 44,268 | 23,521 | $2.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 19,727 | 13,102 | $1.33M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 4.5% | 8,284 | 4,960 | $522K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 2.0% | 3,583 | 2,113 | $234K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.5% | 4,819 | 4,396 | $176K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 10,833 | 7,485 | $140K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,642 | 1,187 | $115K |
| 81025 | <1% | 17,633 | 8,313 | $99K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 482 | 478 | $49K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 577 | 519 | $21K |
7 more codes
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 240 | $19K |
| 90837 | Psychotherapy session, about an hour | <1% | 271 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 479 | $13K |
| 99051 | <1% | 307 | $3K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 115 | $3K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 35 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $160.82 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANTONEVICH, OXANA (DIRECTOR)